Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/31/1969
Centro de Investigaciones Metabólicas (CINME)
mi
from
Ciudad Autonoma de Buenos Aire,
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/31/1969
Centro de Investigaciones Metabólicas (CINME)
mi
from
Ciudad Autonoma de Buenos Aire,
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Total Skin and Beauty Dermatology Center, PC /ID# 154000
mi
from
Birmingham, AL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Total Skin and Beauty Dermatology Center, PC /ID# 154000
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
University of Alabama /ID# 153983
mi
from
Birmingham, AL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
University of Alabama /ID# 153983
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
NW Arkansas Clin Trials Center /ID# 154014
mi
from
Rogers, AR
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
NW Arkansas Clin Trials Center /ID# 154014
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Bakersfield Derma & Skin Cance /ID# 154008
mi
from
Bakersfield, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Bakersfield Derma & Skin Cance /ID# 154008
mi
from
Bakersfield, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Wallace Medical Group, Inc. /ID# 154025
mi
from
Beverly Hills, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Wallace Medical Group, Inc. /ID# 154025
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
CA Dermatology & Clinical Rese /ID# 154007
mi
from
Encinitas, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
CA Dermatology & Clinical Rese /ID# 154007
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
T. Joseph Raoof, MD, Inc. /ID# 154078
mi
from
Encino, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
T. Joseph Raoof, MD, Inc. /ID# 154078
mi
from
Encino, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Center for Dermatology Clin Res /ID# 154009
mi
from
Fremont, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Center for Dermatology Clin Res /ID# 154009
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Los Angeles /ID# 154079
mi
from
Los Angeles, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Los Angeles /ID# 154079
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Dermatology Res. Assoc., CA /ID# 153977
mi
from
Los Angeles, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Dermatology Res. Assoc., CA /ID# 153977
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Dermatology Specialists, Inc. /ID# 153984
mi
from
Oceanside, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Dermatology Specialists, Inc. /ID# 153984
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Huntington Medical Foundation /ID# 154002
mi
from
Pasadena, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Huntington Medical Foundation /ID# 154002
mi
from
Pasadena, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Medderm Associates /ID# 154098
mi
from
San Diego, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Medderm Associates /ID# 154098
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Southern California Derma. Inc /ID# 154006
mi
from
Santa Ana, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Southern California Derma. Inc /ID# 154006
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
UNISON Center for Clinical Tri /ID# 153979
mi
from
Sherman Oaks, CA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
UNISON Center for Clinical Tri /ID# 153979
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
New England Research Associates, LLC /ID# 154004
mi
from
Bridgeport, CT
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
New England Research Associates, LLC /ID# 154004
mi
from
Bridgeport, CT
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
UConn Health /ID# 154128
mi
from
Farmington, CT
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
UConn Health /ID# 154128
mi
from
Farmington, CT
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Florida Academic Centers Research /ID# 154045
mi
from
Coral Gables, FL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Florida Academic Centers Research /ID# 154045
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Leavitt Medical Associates of Florida /ID# 154046
mi
from
Ormond Beach, FL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Leavitt Medical Associates of Florida /ID# 154046
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Progressive Medical Research /ID# 154027
mi
from
Port Orange, FL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research /ID# 154027
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
ATL Derma, Vein & Res Ctr /ID# 153980
mi
from
Alpharetta, GA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
ATL Derma, Vein & Res Ctr /ID# 153980
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Europaeisches Brusstzentrum /ID# 153999
mi
from
Atlanta, GA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Europaeisches Brusstzentrum /ID# 153999
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Northwestern University /ID# 153974
mi
from
Chicago, IL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Northwestern University /ID# 153974
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center /ID# 154099
mi
from
Chicago, IL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center /ID# 154099
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
NorthShore Univ HealthSystem /ID# 154011
mi
from
Evanston, IL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
NorthShore Univ HealthSystem /ID# 154011
mi
from
Evanston, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Arlington Dermatology /ID# 153975
mi
from
Rolling Meadows, IL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Arlington Dermatology /ID# 153975
mi
from
Rolling Meadows, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Dundee Dermatology /ID# 154110
mi
from
West Dundee, IL
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Dundee Dermatology /ID# 154110
mi
from
West Dundee, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
The Indiana Clin Trials Ctr /ID# 153976
mi
from
Indianapolis, IN
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
The Indiana Clin Trials Ctr /ID# 153976
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Dawes Fretzin, LLC /ID# 154146
mi
from
Indianapolis, IN
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Dawes Fretzin, LLC /ID# 154146
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
The Dermatology Center PSC - New Albany /ID# 154075
mi
from
New Albany, IN
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
The Dermatology Center PSC - New Albany /ID# 154075
mi
from
New Albany, IN
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
The South Bend Clinic Center /ID# 154147
mi
from
South Bend, IN
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
The South Bend Clinic Center /ID# 154147
mi
from
South Bend, IN
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Kansas City Dermatology PA /ID# 153993
mi
from
Overland Park, KA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Kansas City Dermatology PA /ID# 153993
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Skin Sciences, PLLC /ID# 153991
mi
from
Louisville, KY
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Skin Sciences, PLLC /ID# 153991
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
DS Research /ID# 154028
mi
from
Louisville, KY
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
DS Research /ID# 154028
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital /ID# 153990
mi
from
Boston, MA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital /ID# 153990
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices and Researc /ID# 154044
mi
from
Methuen, MA
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices and Researc /ID# 154044
mi
from
Methuen, MA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
University of Michigan Hospitals /ID# 154111
mi
from
Ann Arbor, MI
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
University of Michigan Hospitals /ID# 154111
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Great Lakes Research Group, Inc. /ID# 153998
mi
from
Bay City, MI
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Great Lakes Research Group, Inc. /ID# 153998
mi
from
Bay City, MI
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Michigan Center for Skin Care /ID# 153986
mi
from
Clinton Township, MI
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Michigan Center for Skin Care /ID# 153986
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Somerset Skin Centre /ID# 154097
mi
from
Troy, MI
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Somerset Skin Centre /ID# 154097
mi
from
Troy, MI
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Minnesota Clinical Study Center /ID# 154015
mi
from
Fridley, MN
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Minnesota Clinical Study Center /ID# 154015
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Central Dermatology, PC /ID# 154013
mi
from
Saint Louis, MO
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Central Dermatology, PC /ID# 154013
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Skin Specialists, PC /ID# 154024
mi
from
Omaha, NE
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Skin Specialists, PC /ID# 154024
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Dartmouth-Hitchcock Medical Center /ID# 154095
mi
from
Lebanon, NH
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Dartmouth-Hitchcock Medical Center /ID# 154095
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Psoriasis Treatment Ctr NJ /ID# 154001
mi
from
East Windsor, NJ
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Psoriasis Treatment Ctr NJ /ID# 154001
mi
from
East Windsor, NJ
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
The Dermatology Group, PC /ID# 202489
mi
from
Verona, NJ
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
The Dermatology Group, PC /ID# 202489
mi
from
Verona, NJ
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Forest Hills Dermatology Group /ID# 154113
mi
from
Forest Hills, NY
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Forest Hills Dermatology Group /ID# 154113
mi
from
Forest Hills, NY
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
Icahn School of Med Mt. Sinai /ID# 154129
mi
from
New York, NY
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
Icahn School of Med Mt. Sinai /ID# 154129
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated:  12/31/1969
The Rockefeller University /ID# 153994
mi
from
New York, NY
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Status: Enrolling
Updated: 12/31/1969
The Rockefeller University /ID# 153994
mi
from
New York, NY
Click here to add this to my saved trials